Effectiveness of transitioning from omalizumab to dupilumab in chronic spontaneous urticaria patients with inadequate response to omalizumab. [PDF]
Hayama K, Ito-Watanabe M, Fujita H.
europepmc +1 more source
An Overview of Chronic Spontaneous Urticaria: Diagnosis, Management, and Treatment. [PDF]
Tbakhi B +4 more
europepmc +1 more source
Prognostic utility of pre-biologic treatment correlates of childhood severe asthma exacerbation risk: Real world evidence. [PDF]
Owora AH +4 more
europepmc +1 more source
Duo biologic therapy using mepolizumab and omalizumab in refractory ABPA: two cases. [PDF]
Huang IH +4 more
europepmc +1 more source
[Severe anaphylaxis following administration of omalizumab]. [PDF]
Keidel F, Wölbing P, Schäkel K.
europepmc +1 more source
Omalizumab for cholinergic pruritus in a renal transplant and hemodialysis patient. [PDF]
Shu Q, Zhong X, Zhang L, Wang Q.
europepmc +1 more source
Unusual Presentation of Bullous Pemphigoid as Erythroderma in an Elderly Male. [PDF]
Thind A, Stephen, Singh A, Kaur S.
europepmc +1 more source
Comparative Efficacy of Combined and Standalone Oral Immunotherapies for Peanut Allergy: a Bayesian Network Meta-Analysis of RCTs. [PDF]
Tian X, Liu S, Li L, Guan K.
europepmc +1 more source
Biologic relief without the price tag: the promise of omlcylo in atopic asthma and chronic spontaneous urticaria. [PDF]
Mumtaz A, Shahid K, Khalid M, Waafira A.
europepmc +1 more source

